Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Stage 1 To assess the safety and tolerability of SGI-110+carboplatin and determine the maximum tolerated dose (MTD) for Stage 2 Stage 2 To assess and compare progression free survival (PFS) between SGI-110+carboplatin and Treatment Choice (TC) arms
Critère d'inclusion
- Platinum-Resistant Recurrent Ovarian Cancer